HYB:F:F-HOYA Corporation (EUR)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 110.95

Change

-0.30 (-0.27)%

Market Cap

USD 37.25B

Volume

181.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
IUI1:F Intuitive Surgical Inc

-1.05 (-0.29%)

USD 128.13B
ESLC:F ESSILORLUXOTTICA 1/2/O.N.

-1.00 (-0.97%)

USD 95.93B
ESL:F EssilorLuxottica Société ano..

+1.60 (+0.77%)

USD 92.21B
BOX:F Becton Dickinson and Company

-0.70 (-0.32%)

USD 64.97B
HYB0:F HOYA CORP. ADR/ 1 O.N.

-3.00 (-2.63%)

USD 37.87B
RMEA:F Resmed Inc DRC

N/A

USD 29.63B
RME:F ResMed Inc

-3.20 (-1.58%)

USD 29.14B
CBHD:F Coloplast A/S

+1.20 (+1.07%)

USD 28.11B
CBH:F COLOPLAST SP.ADR 1/10 DK1

-0.10 (-0.90%)

USD 25.50B
WPS:F West Pharmaceutical Services I..

+2.80 (+0.87%)

USD 24.79B

ETFs Containing HYB:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.67% 60% D- 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.67% 50% F 43% F
Trailing 12 Months  
Capital Gain 13.61% 84% B 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.61% 77% C+ 60% D-
Trailing 5 Years  
Capital Gain 78.95% 87% B+ 82% B
Dividend Return 72.58% 89% A- 73% C
Total Return 151.53% 87% B+ 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 10.89% 80% B- 77% C+
Dividend Return 17.42% 80% B- 80% B-
Total Return 6.54% 83% B 70% C-
Risk Return Profile  
Volatility (Standard Deviation) 32.93% 34% F 33% F
Risk Adjusted Return 52.92% 88% B+ 82% B
Market Capitalization 37.25B 95% A 95% A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector